Libra Therapeutics Investors

25 investors on Angel Roster list Libra Therapeutics in their portfolio. Most are venture capital firms and corporate venture capital firms, the most common stage is Seed and the largest groups are based in the United States, the United Kingdom and Germany.

Investors are matched on the company name in their portfolio, so companies that share the name Libra Therapeutics can appear together.

Investors listed
25
With verified email
48%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 25 Libra Therapeutics investors

The most complete profiles first. Showing 25 of 25.

  • Debbie LinVerified

    Venture Capital, Corporate Venture Capital, Investor · United States

    SeedHealth CareHospitalsWellnessWomen Founded

    Portfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 36 more

    Verified email available

  • Dennis McWilliamsVerified

    Venture Capital, Investor · United States

    SeedHealth CareTelecommunicationsHospitalsWellness

    Portfolio: HNI Healthcare, Ketra, Healthcare Highways, Nirogy Therapeutics and 32 more

    Verified email available

  • Derek DedekerVerified

    Venture Capital, Investor · United States

    SeedHealth CareTelecommunicationsHospitalsWellness

    Portfolio: HNI Healthcare, Ketra, Healthcare Highways, Nirogy Therapeutics and 31 more

    Verified email available

  • Douglas FrenchVerified

    Venture Capital, Investor · United States

    SeedHealth CareTelecommunicationsHospitalsWellness

    Portfolio: HNI Healthcare, Ketra, Healthcare Highways, Nirogy Therapeutics and 31 more

    Verified email available

  • Joe CunninghamVerified

    Venture Capital, Investor · United States

    SeedHealth CareTelecommunicationsHospitalsWellness

    Portfolio: HNI Healthcare, Ketra, Healthcare Highways, Nirogy Therapeutics and 31 more

    Verified email available

  • Johannes ZanzingerVerified

    Venture Capital, Corporate Venture Capital, Investor · Germany

    Series BSeries AHealth CareHospitalsWellnessWomen Founded

    Portfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 36 more

    Verified email available

  • Louis BockVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareTelecommunicationsHospitalsWellness

    Portfolio: HNI Healthcare, Ketra, diaDexus, Healthcare Highways and 33 more

    Contact details available

  • Martin HeideckerVerified

    Venture Capital, Corporate Venture Capital, Private Equity Firm · United States

    SeedHealth CareHospitalsWellnessWomen Founded

    Portfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 36 more

    Verified email available

  • Casey CunninghamVerified

    Venture Capital · United States

    Health CareTelecommunicationsHospitalsWellness

    Portfolio: HNI Healthcare, Ketra, Healthcare Highways, Nirogy Therapeutics and 31 more

    Contact details available

  • David KaufmanVerified

    Venture Capital · United States

    Health CareTelecommunicationsHospitalsWellness

    Portfolio: HNI Healthcare, Ketra, Healthcare Highways, Nirogy Therapeutics and 31 more

    Verified email available

  • Derek MazurVerified

    Venture Capital · United States

    Health CareTelecommunicationsHospitalsWellness

    Portfolio: HNI Healthcare, Ketra, Healthcare Highways, Nirogy Therapeutics and 31 more

    Verified email available

  • Detlev MennerichVerified

    Corporate Venture Capital · Germany

    Health CareHospitalsWellnessWomen Founded

    Portfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 35 more

    Verified email available

  • James EadieVerified

    Venture Capital · United States

    Health CareTelecommunicationsHospitalsWellness

    Portfolio: HNI Healthcare, Ketra, Healthcare Highways, Nirogy Therapeutics and 31 more

    Verified email available

  • Mary CanningVerified

    Venture Capital, Private Equity Firm, Micro VC · United Kingdom

    Health CareGeneticsChemicalLife Science

    Portfolio: Confluence Life Sciences, Funderbeam, Edinburgh Molecular Imaging, Topas Therapeutics and 14 more

    Verified email available

  • Eric Epstein

    Venture Capital, Investor · United States

    SeedHealth CareTelecommunicationsHospitalsWellness

    Portfolio: HNI Healthcare, Ketra, Healthcare Highways, Nirogy Therapeutics and 31 more

    Contact details available

  • Kevin Lalande

    Venture Capital, Investor · United States

    SeedHealth CareTelecommunicationsHospitalsWellness

    Portfolio: HNI Healthcare, Ketra, Healthcare Highways, Nirogy Therapeutics and 31 more

    Contact details available

  • Oliver Reuss

    Venture Capital, Corporate Venture Capital, Investor · Germany

    Series BSeries AHealth CareHospitalsWellnessWomen Founded

    Portfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 35 more

    Contact details available

  • Sebastian Kreuz

    Venture Capital, Corporate Venture Capital, Investor · Germany

    Series BSeries AHealth CareHospitalsWellnessWomen Founded

    Portfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 35 more

    Contact details available

  • Aksana Labokha

    Micro VC · United Kingdom

    Health CareGeneticsChemicalLife Science

    Portfolio: Confluence Life Sciences, Funderbeam, Edinburgh Molecular Imaging, Topas Therapeutics and 14 more

    Contact details available

  • Elizabeth Roper

    Venture Capital, Private Equity Firm, Micro VC · United Kingdom

    Health CareGeneticsChemicalLife Science

    Portfolio: Confluence Life Sciences, Funderbeam, Edinburgh Molecular Imaging, Topas Therapeutics and 14 more

    Contact details available

  • Ilka Wicke Dr.

    Corporate Venture Capital · Germany

    Health CareHospitalsWellnessWomen Founded

    Portfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 35 more

    Contact details available

  • Jason Brandt , CPA

    Venture Capital · United States

    Health CareTelecommunicationsHospitalsWellness

    Portfolio: HNI Healthcare, Ketra, Healthcare Highways, Nirogy Therapeutics and 31 more

    Contact details available

  • Matthew Miessau

    Venture Capital, Private Equity Firm, Micro VC · United States

    Health CareGeneticsChemicalLife Science

    Portfolio: Confluence Life Sciences, Funderbeam, Edinburgh Molecular Imaging, Topas Therapeutics and 14 more

    Contact details available

  • Peter Finan

    Micro VC · United Kingdom

    Health CareGeneticsChemicalLife Science

    Portfolio: Confluence Life Sciences, Funderbeam, Edinburgh Molecular Imaging, Topas Therapeutics and 14 more

    Contact details available

  • Sinclair Dunlop

    Venture Capital, Private Equity Firm, Micro VC · United Kingdom

    Health CareGeneticsChemicalLife Science

    Portfolio: Confluence Life Sciences, Funderbeam, Edinburgh Molecular Imaging, Topas Therapeutics and 14 more

    Contact details available

Frequently asked questions

How many Libra Therapeutics investors are on Angel Roster?

Angel Roster lists 25 Libra Therapeutics investors. 12 of them (48%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (21), Corporate Venture Capital Firms (7) and Private Equity Firms (6). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Libra Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (9), Series A (3) and Series B (3).

Where are Libra Therapeutics investors based?

Most are based in the United States (15), the United Kingdom (5) and Germany (5).

Which companies have Libra Therapeutics investors backed?

The most-backed portfolio companies among them are Topas Therapeutics (13), Renascent Medical (12), Molecular Templates (12), RiseHealth (12) and AbVitro (12).

How do I contact Libra Therapeutics investors?

Create a free Angel Roster account to search and filter all 25, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.